
1. Lancet Psychiatry. 2021 Dec;8(12):1019-1021. doi: 10.1016/S2215-0366(21)00431-4.

Beyond access to psychotropic medicines: treatment coverage amid COVID-19.

Kola L(1).

Author information: 
(1)WHO Collaborating Centre for Research and Training in Mental Health,
Neurosciences and Drug and Alcohol Abuse, Ibadan, Nigeria; Department of
Psychiatry College of Medicine University of Ibadan, Ibadan, Nigeria; BRiTE
Center, Department of Psychiatry and Behavioral Sciences, University of
Washington, Seattle, WA, USA. Electronic address: lola_kola2004@yahoo.com.

Comment on
    Lancet Psychiatry. 2021 Dec;8(12):1071-1082.

DOI: 10.1016/S2215-0366(21)00431-4 
PMID: 34801114  [Indexed for MEDLINE]

Conflict of interest statement: I declare no competing interests.

